Your browser doesn't support javascript.
loading
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year Results.
Martin, Daniel F; Maguire, Maureen G; Fine, Stuart L; Ying, Gui-Shuang; Jaffe, Glenn J; Grunwald, Juan E; Toth, Cynthia; Redford, Maryann; Ferris, Frederick L.
Afiliação
  • Martin DF; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.
  • Maguire MG; Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Fine SL; Department of Ophthalmology, University of Colorado, Denver, Colorado.
  • Ying GS; Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Jaffe GJ; Department of Ophthalmology, Duke University, Durham, North Carolina.
  • Grunwald JE; Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Toth C; Department of Ophthalmology, Duke University, Durham, North Carolina.
  • Redford M; National Eye Institute, National Institutes of Health, Bethesda, Maryland.
  • Ferris FL; National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Ophthalmology ; 127(4S): S135-S145, 2020 04.
Article em En | MEDLINE | ID: mdl-32200813

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neovascularização de Coroide / Inibidores da Angiogênese / Degeneração Macular Exsudativa / Bevacizumab / Ranibizumab Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ophthalmology Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neovascularização de Coroide / Inibidores da Angiogênese / Degeneração Macular Exsudativa / Bevacizumab / Ranibizumab Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ophthalmology Ano de publicação: 2020 Tipo de documento: Article